BPA
IDXX icon

Beacon Pointe Advisors’s Idexx Laboratories IDXX Stock Holding History

Beacon Pointe Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.26M Sell
4,300
-1,562
-27% -$876K 0.01% 723
2026
Q1 		$3.29M Buy
5,862
+5,058
+629% +$3.24M 0.02% 595
2025
Q4 		$544K Buy
804
+178
+28% +$121K ﹤0.01% 1051
2025
Q3 		$400K Sell
626
-39
-6% -$23.7K ﹤0.01% 1090
2025
Q2 		$357K Buy
+665
New +$318K ﹤0.01% 990
2024
Q4 		– Sell
-627
Closed -$317K – 1239
2024
Q3 		$317K Sell
627
-151
-19% -$73.4K ﹤0.01% 1000
2024
Q2 		$379K Sell
778
-14
-2% -$7.03K ﹤0.01% 972
2024
Q1 		$428K Sell
792
-539
-40% -$295K ﹤0.01% 977
2023
Q4 		$739K Sell
1,331
-100
-7% -$46.9K 0.01% 766
2023
Q3 		$626K Buy
1,431
+652
+84% +$325K 0.01% 788
2023
Q2 		$391K Sell
779
-719
-48% -$345K 0.01% 794
2023
Q1 		$749K Buy
1,498
+700
+88% +$335K 0.01% 625
2022
Q4 		$326K Buy
+798
New +$310K 0.01% 837
2022
Q2 		– Sell
-6,094
Closed -$3.33M – 1133
2022
Q1 		$3.33M Buy
6,094
+5,502
+929% +$2.89M 0.05% 332
2021
Q4 		$390K Buy
592
+201
+51% +$126K 0.01% 639
2021
Q3 		$243K Sell
391
-371
-49% -$249K 0.01% 785
2021
Q2 		$481K Buy
+762
New +$421K 0.02% 489

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Beacon Pointe Advisors's IDXX Position: Q2 2026 in Review

Beacon Pointe Advisors reduced its Idexx Laboratories (IDXX) stake by 27% in Q2 2026, selling an estimated $876K and leaving 4,300 shares worth $2.26M. The position accounts for 0.01% of the portfolio, ranked #723.

Beacon Pointe Advisors first reported a position in IDXX in Q2 2021 and has held it in 17 quarters since. The position peaked at $3.33M in Q1 2022. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Beacon Pointe Advisors held 4,300 shares of Idexx Laboratories worth $2.26M as of Q2 2026.
  • Beacon Pointe Advisors sold 1,562 Idexx Laboratories shares in Q2 2026, an estimated $876K.
  • Idexx Laboratories made up 0.01% of Beacon Pointe Advisors's portfolio in Q2 2026, its #723 holding.
  • Beacon Pointe Advisors first reported a position in Idexx Laboratories in Q2 2021 and has held it in 17 quarters since.
  • Beacon Pointe Advisors's Idexx Laboratories position peaked at $3.33M in Q1 2022.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Beacon Pointe Advisors's 13F filing for Q2 2026, filed 18 Aug 2026.